# 1910 Genetics

> 1910 Genetics (now branded 1910) is an AI-native biotechnology company advancing small and large molecule drug discovery with a multimodal AI platform powered by high-throughput laboratory automation. Its ITO platform integrates computational, wet-lab proxy, and wet-lab ground-truth biological data to pursue "modality agnostic" drug discovery. As of this profile the company publishes no public API, SDK, or developer documentation surface; it offers co-engineering collaborations to pharma and technology partners.

## Company
- [Website](https://www.1910.ai/): AI-native biotech drug-discovery company (canonical domain, formerly 1910genetics.com)
- [Platform](https://www.1910.ai/platform): ITO multimodal AI drug-discovery platform, plus PEGASUS and CANDID-CNS AI models
- [Careers](https://www.1910.ai/careers): open engineering and scientific roles
- [Contact](https://www.1910.ai/contact-us): business development — bd@1910.ai

## Legal
- [Privacy Policy](https://www.1910.ai/privacy-policy)
- [Terms & Conditions](https://www.1910.ai/terms-conditions)

## Network
- [APIs.json](https://raw.githubusercontent.com/api-evangelist/1910-genetics/refs/heads/main/apis.yml): API Evangelist network profile for 1910 Genetics
- Backed by: [Playground Global](https://www.1910.ai/)

## Notes
- No public REST/GraphQL API, OpenAPI/AsyncAPI specification, SDK, CLI, or MCP server is published at this time.
- Engagement is via co-engineering collaborations rather than a self-serve developer platform.